Track topics on Twitter Track topics that are important to you
In response to receiving a double dose of good news from the Food and Drug Administration and some bullish commentary from Wall Street, shares of Impax Laboratories , a maker of generic and branded pharmaceutical products, rose 18% in July, according to data from S&P Global Market Intelligence . Impax shared two upbeat regulatory news items with investors during the month.
Original Article: Here's Why Impax Laboratories Inc Jumped 18% In JulyNEXT ARTICLE
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...